UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Vaccine, 2020-07, Vol.38 (33), p.5119-5122

2020

Volltextzugriff (PDF)

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

Journal of adolescent health, 2009, Vol.44 (1), p.33-40

2009

Volltextzugriff (PDF)

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18

International journal of cancer, 2012-07, Vol.131 (1), p.106-116

2012

Volltextzugriff (PDF)

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Vaccine, 2013-11, Vol.31 (47), p.5500-5505

Osazuwa-Peters, N

2013

Volltextzugriff (PDF)

Provider Recommendation Mediates the Relationship Between Parental Human Papillomavirus (HPV) Vaccine Awareness and HPV Vaccine Initiation and Completion Among 13- to 17-Year-Old US Adolescent Children

Clinical pediatrics, 2015-04, Vol.54 (4), p.371-375

2015

Volltextzugriff (PDF)

'I didn't even know boys could get the vaccine': Parents' reasons for human papillomavirus (HPV) vaccination decision making for their sons

Psycho-oncology (Chichester, England), 2015-10, Vol.24 (10), p.1316-1323

2015

Volltextzugriff (PDF)

AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®): A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types

Drugs (New York, N.Y.), 2011-03, Vol.71 (4), p.465-488

2011

Volltextzugriff (PDF)

Prevalence of high‐risk human papillomavirus after HPV‐vaccination in Denmark

International journal of cancer, 2020-12, Vol.147 (12), p.3446-3452

2020

Volltextzugriff (PDF)

Kosovo women's knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer

BMC women's health, 2021-10, Vol.21 (1), p.354-6, Article 354

2021

Volltextzugriff (PDF)

Abandoning Medical Authority: When Medical Professionals Confront Stigmatized Adolescent Sex and the Human Papillomavirus (HPV) Vaccine

Journal of health and social behavior, 2019-06, Vol.60 (2), p.240-256

Fenton, Anny T.

2019

Volltextzugriff (PDF)

Human papillomavirus (HPV) vaccination in Japan

The journal of obstetrics and gynaecology research, 2024-10, Vol.50 (S1), p.65-71

Miyagi, Etsuko

2024

Volltextzugriff (PDF)

Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review

CA: a cancer journal for clinicians, 2022-11, Vol.72 (6), p.561-569

2022

Volltextzugriff (PDF)

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries

PloS one, 2017-06, Vol.12 (6), p.e0177773-e0177773

2017

Volltextzugriff (PDF)

Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019

Vaccine, 2022-03, Vol.40 (Suppl 1), p.A38-A48

2022

Volltextzugriff (PDF)

Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006-2015): a need for evidence-based policy

Risk management and healthcare policy, 2017-01, Vol.10, p.29-32

2017

Volltextzugriff (PDF)

Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta‐analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status

Journal of the International AIDS Society, 2018-06, Vol.21 (6), p.e25110-n/a

2018

Volltextzugriff (PDF)

“Saving lives”: Adapting and adopting Human Papilloma Virus (HPV) vaccination in Austria

Social science & medicine (1982), 2016-03, Vol.153, p.193-200

Paul, Katharina T.

2016

Volltextzugriff (PDF)

Awareness about the human papillomavirus (HPV) and HPV vaccine among medical students in Lebanon

Journal of medical virology, 2022-06, Vol.94 (6), p.2796-2801

2022

Volltextzugriff (PDF)

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

BMC public health, 2012-10, Vol.12 (1), p.872-872, Article 872

2012

Volltextzugriff (PDF)

Healthcare professional’s promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review

Vaccine, 2022-04, Vol.40 (19), p.2656-2666

2022

Volltextzugriff (PDF)

Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India–2018–2019

Vaccine, 2022-03, Vol.40 (Suppl 1), p.A17-A25

2022

Volltextzugriff (PDF)

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction

Vaccine, 2022-03, Vol.40, p.A26-A29

2022

Volltextzugriff (PDF)

Potential cost‐effectiveness of the nonavalent human papillomavirus (HPV) vaccine

International journal of cancer, 2014-05, Vol.134 (9), p.2264-2268

2014

Volltextzugriff (PDF)

"You Don't Know If It's the Truth or a Lie": Exploring Human Papillomavirus (HPV) Vaccine Hesitancy among Communities with Low HPV Vaccine Uptake in Northern California

Vaccines (Basel), 2024-04, Vol.12 (4), p.372

2024

Volltextzugriff (PDF)

Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands

Vaccine, 2011-06, Vol.29 (28), p.4601-4607

2011

Volltextzugriff (PDF)

1 – 25 von 9.707

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

ThemaMiddle Aged

Nur zeigenGeprüft (Peer-Review)

ThemaVaccines

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(8.492)

Publikationsform

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(8.139)
Life Sciences & Biomedicine
(7.535)
Human Papillomavirus
(6.757)
Immunization
(4.992)
Humans
(4.887)
Cervical Cancer
(3.525)
Vaccination
(3.369)
Female
(3.175)
Immunology
(2.824)
Medicine, Research & Experimental
(2.283)
Research & Experimental Medicine
(2.282)
Public Health
(2.172)
Papillomavirus Infections - Prevention & Control
(2.093)
Infections
(2.044)
Cancer
(1.890)
Adolescent
(1.756)
Womens Health
(1.650)
Public, Environmental & Occupational Health
(1.291)
Infectious Diseases
(1.246)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years

Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18

Human papillomavirus (HPV), HPV-associated oropharyngeal cancer, and HPV vaccine in the United States—Do we need a broader vaccine policy?

Provider Recommendation Mediates the Relationship Between Parental Human Papillomavirus (HPV) Vaccine Awareness and HPV Vaccine Initiation and Completion Among 13- to 17-Year-Old US Adolescent Children

'I didn't even know boys could get the vaccine': Parents' reasons for human papillomavirus (HPV) vaccination decision making for their sons

AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®): A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types

Prevalence of high‐risk human papillomavirus after HPV‐vaccination in Denmark

Kosovo women's knowledge and awareness of human papillomavirus (HPV) infection, HPV vaccination, and its relation to cervical cancer

Abandoning Medical Authority: When Medical Professionals Confront Stigmatized Adolescent Sex and the Human Papillomavirus (HPV) Vaccine

Human papillomavirus (HPV) vaccination in Japan

Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: A systematic review

Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries

Tanzania’s human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019

Legislative activity related to the human papillomavirus (HPV) vaccine in the United States (2006-2015): a need for evidence-based policy

Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta‐analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status

“Saving lives”: Adapting and adopting Human Papilloma Virus (HPV) vaccination in Austria

Awareness about the human papillomavirus (HPV) and HPV vaccine among medical students in Lebanon

Modeling the impact of the difference in cross-protection data between a human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and a human papillomavirus (HPV)-6/11/16/18 vaccine in Canada

Healthcare professional’s promotional strategies in improving Human papillomavirus (HPV) vaccination uptake in adolescents: A systematic review

Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India–2018–2019

Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania’s national HPV vaccine introduction

Potential cost‐effectiveness of the nonavalent human papillomavirus (HPV) vaccine

"You Don't Know If It's the Truth or a Lie": Exploring Human Papillomavirus (HPV) Vaccine Hesitancy among Communities with Low HPV Vaccine Uptake in Northern California

Reported adverse events in girls aged 13–16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands

Aktive Filter

Suchergebnisse filtern